Joseph Hargett

Joseph Hargett

InvestorPlace Contributor

Despite hailing from the Greater Cincinnati, Ohio area, Joseph Hargett has spent nearly the past decade elbow-deep in Wall Street.  Specializing in financial writing, options strategies and stock-market analysis, Joseph cut his teeth in the research department of Cincinnati-based Schaeffer’s Investment Research.

While at Schaeffer’s, Joseph wrote market, stock and options commentary for SchaeffersResearch.com, and was lead editor for The Options Advisor (the nation’s leading options newsletter).

Joseph has since moved on to become a prolific Forbes contributor in the options realm, as well as a lead copy editor and contributor for a well respected investment newsletter publisher.  Joseph’s commentary has appeared in a plethora of media outlets, including The Wall Street Journal, The New York Times, Money Show Digest, Reuters, CBE MarketWatch and Sentiment Magazine.

Recent Articles

Tuesday’s Vital Data: Valeant Pharmaceuticals Intl Inc (VRX), Vale SA (ADR) (VALE) and Chesapeake Energy Corporation (CHK)

By Joseph Hargett, InvestorPlace Contributor

Valeant (VRX) bombs 1Q earnings, Vale SA (VALE) options see follow-through and Chesapeake Energy (CHK) calls are up on gas and oil prices.

Monday’s Vital Data: Bank of America Corp (BAC), Apple Inc. (AAPL) and Citigroup Inc (C)

By Joseph Hargett, InvestorPlace Contributor

Bank of America (BAC) falters on rate-hike delay concerns, Apple (AAPL) options ramp up on Echo competitor speculation and Citigroup (C) cuts Q2 expectations.

Valeant Pharmaceuticals Intl Inc: Take a Valiant Stand Ahead of Earnings (VRX)

By Joseph Hargett, InvestorPlace Contributor

With Valeant's financial issues already priced in, VRX stock could be in for a post-earnings rally as negative sentiment unwinds.

Friday’s Vital Data: Micron Technology, Inc. (MU), Oracle Corporation (ORCL) and Sarepta Therapeutics Inc (SRPT)

By Joseph Hargett, InvestorPlace Contributor

Micron (MU) call options pile up as resistance looms, Oracle (ORCL) falters on a whistleblower lawsuit and Sarepta (SRPT) is pummeled by an FDA rules change.

Thursday’s Vital Data: Apple Inc. (AAPL), Alibaba Group Holding Ltd (BABA) and Valeant Pharmaceuticals Intl Inc (VRX)

By Joseph Hargett, InvestorPlace Contributor

Apple (AAPL) is downgraded at Goldman, Alibaba (BABA) options are up on SoftBank stake decrease and Valeant (VRX) sets 1Q earnings date.

Can Ambarella Inc (AMBA) Move Out of GoPro Inc’s Shadow?

By Joseph Hargett, InvestorPlace Contributor

With GoPro problems already priced in, AMBA stock looks ready to rally as Ambarella broadens its revenue base.

Wednesday’s Vital Data: Apple Inc. (AAPL), Michael Kors Holdings Ltd (KORS) and Micron Technology, Inc. (MU)

By Joseph Hargett, InvestorPlace Contributor

Apple (AAPL) is plagued by rumors of a longer iPhone refresh cycle, Michael Kors (KORS) blows out earnings and Micron (MU) options rise on analyst upgrades.

Tuesday’s Vital Data: Alibaba Group Holding Ltd (BABA), Bank of America Corp (BAC) and Tesla Motors Inc (TSLA)

By Joseph Hargett, InvestorPlace Contributor

Alibaba (BABA) was bolstered by bullish comments, BofA (BAC) options are up on technicals and Tesla (TSLA) sets a date for its gigafactory.

Friday’s Vital Data: Netflix, Inc. (NFLX), Apple Inc. (AAPL) and Tesla Motors Inc (TSLA)

By Joseph Hargett, InvestorPlace Contributor

Netflix (NFLX) call options rally on Apple (AAPL) acquisition speculation while Tesla Motors (TSLA) breakout drives technical buying activity.

Thursday’s Vital Data: Alibaba Group Holding Ltd (BABA), Yahoo! Inc. (YHOO) and Sarepta Therapeutics Inc (SRPT)

By Joseph Hargett, InvestorPlace Contributor

Alibaba (BABA) put options pile on SEC investigation, Yahoo! (YHOO) calls soar on AT&T (T) bid and Sarepta (SRPT) spikes on FDA delay.

Load More